SMARCA4 and non-small cell lung carcinoma: Mutation analysis of the SMARCA4 gene revealed a unique pattern of mutations that were mutually exclusive with the most common target oncogene mutations in non-small cell lung cancer (NSCLC), such as EGFR, ALK, MET, ROS1, and RET. This finding was consistent with the genetic testing results of this patient.